Skip to main content

Advertisement

Fig. 6 | Cell & Bioscience

Fig. 6

From: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway

Fig. 6

MiR-622 inhibits CCL18 activated MAPK signal pathway in OS-RC-2 and ACHN cells. a OS-RC-2 and ACHN cells were transfected with miR-622 mimics or treated with CCL18 and then the molecules associated with MAPK signal pathway were detected by western blotting. b, c OS-RC-2 and ACHN cells were transfected with miR-622 mimics or treated with CCL18 and the mRNA levels of cdc25, CREB, c-Fos, Mad1 were measured by RT-PCR. *P < 0.05; **P < 0.01

Back to article page